Antitrust
Viewpoints
Filter by:
In Split Vote, FTC Approves Controversial Final Rule Banning Most Post-Employment Non-Competes; Rule Already Subject to Challenge in Court
April 25, 2024 | Blog | By Talia Weseley, Danielle Bereznay, Bruce Sokler, Benjamin Ferrucci, David Barmak, Brad M Scheller , Geri Haight, Michael Arnold
FTC Warns AI Companies to Honor Privacy and Confidentiality Commitments — AI: The Washington Report
January 19, 2024 | Blog | By Michael Katz, Bruce Sokler, Alexander Hecht, Christian Tamotsu Fjeld, Raj Gambhir
New Merger Enforcement Toolkit: FTC and DOJ Release Final 2023 Merger Guidelines
December 27, 2023 | Blog | By Bruce Sokler, Joseph Miller , Robert Kidwell, Payton Thornton, Matthew Tikhonovsky
Indecent Disclosure: FTC Slams Advertisers and Influencers for Failure to Divulge Material Connections
November 17, 2023 | Blog | By Bruce Sokler, Sherwet H. Witherington
Last June, the Federal Trade Commission (FTC) released its revised Endorsement Guides, the handbook for business practices that may be unfair or deceptive in violation of the FTC Act. The Endorsement Guides had been last revised in 2009 and the recent revisions sought to align practices with the ways advertisers reach consumers to promote products and services, including on social media.
Read more
FTC Follows Through on Promise to Roll Over Health Care Roll Ups
September 26, 2023 | Blog | By Bruce Sokler, Joseph Miller , Payton Thornton
Since the beginning of Chair Khan’s tenure at the Federal Trade Commission (and in line with President Biden’s aim to curb rising health care costs), the current FTC has committed to bring enforcement actions against health care consolidation and rising prices. Over the past two years the FTC has employed novel competition tools to achieve this purpose, as demonstrated by the Commission’s suit last week against a private equity firm and its related specialty practice—alleging violations of Sections 1 and 2 of the Sherman Act, Section 7 of the Clayton Act and Section 5 of the FTC Act.
Read more
The FTC "Settles" For a Conduct Consent Decree to Resolve Its Challenge to the Amgen-Horizon Merger
September 5, 2023 | Blog | By Bruce Sokler, Joseph Miller , Payton Thornton
The National AI Research Resource and the CREATE AI Act — AI: The Washington Report
August 4, 2023 | Blog | By Bruce Sokler, Alexander Hecht, Christian Tamotsu Fjeld, Raj Gambhir
Read about Representative Anna Eshoo’s (D-CA-16) CREATE AI Act, and the National Artificial Intelligence Research Resource that this bill would establish.
Read more
Proposed Overhaul of HSR Premerger Notification Process
June 28, 2023 | Blog | By Farrah Short, Bruce Sokler, Joseph Miller , Robert Kidwell
Unanimous Federal Trade Commission Orders Illumina, Inc. to Divest GRAIL, Inc.
April 5, 2023 | Blog | By Bruce Sokler, Payton Thornton
DOJ Sues Google for Monopolizing Digital Advertising Markets
February 22, 2023 | Blog | By Joseph Miller , Tinny Song
Out with the Old: The Antitrust Division Withdraws Healthcare Enforcement Policy Statements
February 7, 2023 | Blog | By Bruce Sokler, Joseph Miller , Payton Thornton
Is Antitrust ESG's Achilles Heel ? House Republicans Think So.
December 13, 2022 | Blog | By Bruce Sokler, Jacob Hupart, Tinny Song, Payton Thornton
On the Board: DOJ Gets First Win in Criminal No-Poach Prosecution
October 31, 2022 | Blog | By Bruce Sokler, Tinny Song, Payton Thornton
Explore Other Viewpoints:
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- Energy & Sustainability
- Environmental Enforcement Defense
- Environmental Law
- FDA Regulatory
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology